Designed to support healthy gutbrain signaling that influences fullness and appetite
This process evaluates clinical and cost-effectiveness and involves a separate commissioning decision
In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss
Lower fluid intake may also reduce regular bladder flushing, which can increase the risk of urinary tract infections (UTIs) in some individuals
In MCF-7 and T47D cells, the Huaier extract combined with TAM can reduce cell viability and synergistically induce cell autophagy, apoptosis, and G0/G1 cell cycle arrest via the inhibition of the AKT/mTOR signaling pathway (Qi et al., 2016)
Relative contraindications include recurrent pancreatitis, gastroparesis, or ongoing unexplained gastrointestinal symptoms